George M Jenkins, Director at Palvella Therapeutics, sold PVLA on Sep 11, 2026
Data as of Oct 16
- Traded
- Sep 11, 2026
- Disclosed
- Sep 15, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
PVLA since disclosure
−20.4%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund
Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$39.6Kdisclosed Sep 15 · filed the same day
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$84.7Kdisclosed Sep 15 · filed the same day
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$143Kdisclosed Sep 15 · filed the same day
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$239Kdisclosed Sep 15 · filed 1 day after the trade
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$853Kdisclosed Sep 15 · filed 1 day after the trade
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$937Kdisclosed Sep 15 · filed 1 day after the trade
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$982Kdisclosed Sep 15 · filed 4 days after the trade
- ▼ SELLGeorge M Jenkins DirectorPVLA Palvella Therapeutics, Inc.$694Kdisclosed Sep 15 · filed 4 days after the trade